These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 36503914)

  • 1. Nanocarriers for the delivery of antibiotics into cells against intracellular bacterial infection.
    Wang C; Yang Y; Cao Y; Liu K; Shi H; Guo X; Liu W; Hao R; Song H; Zhao R
    Biomater Sci; 2023 Jan; 11(2):432-444. PubMed ID: 36503914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanocarriers for antibiotics: a promising solution to treat intracellular bacterial infections.
    Abed N; Couvreur P
    Int J Antimicrob Agents; 2014 Jun; 43(6):485-96. PubMed ID: 24721232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocytosis-mediated redistribution of antibiotics targets intracellular bacteria.
    Qu S; Zhu K
    Nanoscale; 2023 Mar; 15(10):4781-4794. PubMed ID: 36779877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation of host-targeted therapeutics against bacterial infections.
    Varma DM; Zahid MSH; Bachelder EM; Ainslie KM
    Transl Res; 2020 Jun; 220():98-113. PubMed ID: 32268128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging Antibacterial Strategies with Application of Targeting Drug Delivery System and Combined Treatment.
    Zhang W; Hu E; Wang Y; Miao S; Liu Y; Hu Y; Liu J; Xu B; Chen D; Shen Y
    Int J Nanomedicine; 2021; 16():6141-6156. PubMed ID: 34511911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surface modification of nano-drug delivery systems for enhancing antibiotic delivery and activity.
    Osman N; Devnarain N; Omolo CA; Fasiku V; Jaglal Y; Govender T
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Jan; 14(1):e1758. PubMed ID: 34643067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioinspired drug delivery strategies for repurposing conventional antibiotics against intracellular infections.
    Subramaniam S; Joyce P; Thomas N; Prestidge CA
    Adv Drug Deliv Rev; 2021 Oct; 177():113948. PubMed ID: 34464665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Research progress of nanoparticle targeting delivery systems in bacterial infections.
    Jin M; He B; Cai X; Lei Z; Sun T
    Colloids Surf B Biointerfaces; 2023 Sep; 229():113444. PubMed ID: 37453264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the hard to reach: challenges and novel strategies in the treatment of intracellular bacterial infections.
    Kamaruzzaman NF; Kendall S; Good L
    Br J Pharmacol; 2017 Jul; 174(14):2225-2236. PubMed ID: 27925153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Nanoantibiotics": a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era.
    Huh AJ; Kwon YJ
    J Control Release; 2011 Dec; 156(2):128-45. PubMed ID: 21763369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multidisciplinary approach to prostatitis.
    Magri V; Boltri M; Cai T; Colombo R; Cuzzocrea S; De Visschere P; Giuberti R; Granatieri CM; Latino MA; Larganà G; Leli C; Maierna G; Marchese V; Massa E; Matteelli A; Montanari E; Morgia G; Naber KG; Papadouli V; Perletti G; Rekleiti N; Russo GI; Sensini A; Stamatiou K; Trinchieri A; Wagenlehner FME
    Arch Ital Urol Androl; 2019 Jan; 90(4):227-248. PubMed ID: 30655633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineering hybrid nanosystems for efficient and targeted delivery against bacterial infections.
    Elhassan E; Devnarain N; Mohammed M; Govender T; Omolo CA
    J Control Release; 2022 Nov; 351():598-622. PubMed ID: 36183972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The current novel drug delivery system (natural and chemical composites) in dental infections for antibiotics resistance: a narrative review.
    Tahmasebi E; Kaboudanian Ardestani A; Hassani Z; Alam M; Abbasi K; Kahrizi S; Madihi N; Abbasiparashkouh Z; Mohammadi A; Shahab P; Khayatan D; Yazdanian M
    Cell Mol Biol (Noisy-le-grand); 2022 Sep; 68(10):141-160. PubMed ID: 37114257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delivery of Antibiotics by Cell-Penetrating Peptides to Kill Intracellular Pathogens.
    Rüter C
    Methods Mol Biol; 2022; 2383():335-345. PubMed ID: 34766300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expanding therapeutic strategies for intracellular bacterial infections through conjugates of apoptotic body-antimicrobial peptides.
    Nieto Marín V; Buccini DF; Arboleda V JW; Cardoso MH; Franco OL
    Drug Discov Today; 2023 Feb; 28(2):103444. PubMed ID: 36400344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent Advances in Oral Nano-Antibiotics for Bacterial Infection Therapy.
    Wu ZL; Zhao J; Xu R
    Int J Nanomedicine; 2020; 15():9587-9610. PubMed ID: 33293809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antibiotic bedaquiline activates host macrophage innate immune resistance to bacterial infection.
    Giraud-Gatineau A; Coya JM; Maure A; Biton A; Thomson M; Bernard EM; Marrec J; Gutierrez MG; Larrouy-Maumus G; Brosch R; Gicquel B; Tailleux L
    Elife; 2020 May; 9():. PubMed ID: 32369020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial Peptides and Cell-Penetrating Peptides for Treating Intracellular Bacterial Infections.
    Buccini DF; Cardoso MH; Franco OL
    Front Cell Infect Microbiol; 2020; 10():612931. PubMed ID: 33614528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergism between Host Defence Peptides and Antibiotics Against Bacterial Infections.
    Li J; Fernández-Millán P; Boix E
    Curr Top Med Chem; 2020; 20(14):1238-1263. PubMed ID: 32124698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacterial genome engineering and synthetic biology: combating pathogens.
    Krishnamurthy M; Moore RT; Rajamani S; Panchal RG
    BMC Microbiol; 2016 Nov; 16(1):258. PubMed ID: 27814687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.